FIGURE 6.
Distribution of correlations between improvement in fatigue at week 24 compared with baseline and change from baseline in other PBC-40 domains (n=103). (A) Emotional, (B) social, (C) symptom, (D) itch, (E) cognitive. All patients with PBC-40 data available at baseline and week 24 were included in these analyses (n=103); some patients may have stopped setanaxib treatment before the end of the treatment period. Correlation coefficients (r values) were generated using proc corr in SAS (Ver. 9.4). Abbreviation: PBC-40, primary biliary cholangitis-40 item questionnaire.